Biomaterial-Assisted Gene Therapy for Translational Approaches to Treat Musculoskeletal Disorders
Use este enlace para citar
http://hdl.handle.net/2183/27294
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-SA 4.0)
Colecciones
- GI-TCMR - Artigos [123]
Metadatos
Mostrar el registro completo del ítemTítulo
Biomaterial-Assisted Gene Therapy for Translational Approaches to Treat Musculoskeletal DisordersAutor(es)
Fecha
2020-12-28Cita bibliográfica
Venkatesan JK, Rey-Rico A, Meng W, et al. Biomaterial-assisted gene therapy for translational approaches to treat musculoskeletal disorders. Mater. Today Adv. 2021; 9:100126
Resumen
[Abstract]
Biomaterial-assisted gene therapy is a promising strategy for the treatment of various musculoskeletal disorders such as those concerning the articular cartilage, bones, tendons and ligaments, and meniscus as it can deliver candidate gene sequences in a spatially and temporally controlled manner in sites of tissue damage over prolonged periods of time that may be required to durably enhance the specific, natural repair mechanisms in vivo in direct, non-invasive procedures that avoid the arduous manipulation and implantation of patient-dependent cells genetically modified in vitro. In the present work, we provide an overview of the most up-to-date approaches and outcomes in experimental, relevant models of such disorders in vivo using biomaterial-guided gene transfer that may be employed in a near future to treat patients during a clinical intervention as a means to achieve an effective, safe, and persistent translational healing of musculoskeletal injuries.
Palabras clave
Orthopedic diseases
Genetic transfer
Tissue engineering
Genetic transfer
Tissue engineering
Versión del editor
Derechos
Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-SA 4.0)
ISSN
2590-0498